Syros Pharmaceuticals (SYRS) Q2 2024 Earnings

May 14Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-2.18
-1.49
-0.79
-0.1

Details

Expected EPS
-0.84718
Actual EPS
-0.1
Surprise EPS
0.75
Surprise Percent
+88.2%

Description

⁨Syros Pharmaceuticals⁩ (⁦SYRS⁩) has reported earnings of ⁦-0.1⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts